Hyloris Pharmaceuticals SA
XBRU:HYL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hyloris Pharmaceuticals SA
XBRU:HYL
|
BE |
|
D
|
Danaher Corp
LSE:0R2B
|
US |
|
Bakrie Sumatera Plantations Tbk PT
IDX:UNSP
|
ID |
|
H
|
HanPass Co Ltd
KOSDAQ:408470
|
KR |
|
G
|
Green Bridge Industries Inc
OTC:GRBG
|
US |
|
Eastman Chemical Co
NYSE:EMN
|
US |
|
T
|
Toyota Tsusho Corp
TSE:8015
|
JP |
|
N
|
Neotech Metals Corp
OTC:NTMFF
|
CA |
|
OceanaGold Corp
NYSE:OGC
|
CA |
|
Bell Financial Group Ltd
ASX:BFG
|
AU |
|
L
|
Levi Strauss & Co
F:LV2B
|
US |
|
Orient Overseas (International) Ltd
HKEX:316
|
HK |
|
P
|
Power Cement Ltd
KAR:POWER
|
PK |
|
P
|
Pakistan Oilfields Ltd
KAR:POL
|
PK |
Shareholder Yield
Current shareholder yield for HYL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HYL Price
Hyloris Pharmaceuticals SA
| Average Annual Return | -22.76% |
| Standard Deviation of Annual Returns | 28.12% |
| Max Drawdown | -83% |
| Market Capitalization | 102.2m EUR |
| Shares Outstanding | 28 000 000 |
| Percentage of Shares Shorted |
N/A
|
